Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD of Baird Medical Investment Holdings Ltd from Q4 2021 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
Baird Medical Investment Holdings Ltd quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and growth rate from Q4 2021 to Q2 2025.
  • Baird Medical Investment Holdings Ltd Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending June 30, 2025 was $35.6M, a 9.25% decline year-over-year.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Growth (%)

Baird Medical Investment Holdings Ltd Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $35.6M -$3.63M -9.25% Jun 30, 2025 6-K 2025-12-05
Q4 2024 $39.8M +$4.05M +11.4% Dec 31, 2024 6-K 2025-12-05
Q2 2024 $39.3M Jun 30, 2024 6-K 2025-12-05
Q4 2023 $35.7M +$9.93M +38.5% Dec 31, 2023 6-K 2025-12-05
Q4 2022 $25.8M +$11.3M +77.7% Dec 31, 2022 20-F 2025-05-15
Q4 2021 $14.5M Dec 31, 2021 20-F 2025-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.